These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells. Ferch U; Kloo B; Gewies A; Pfänder V; Düwel M; Peschel C; Krappmann D; Ruland J J Exp Med; 2009 Oct; 206(11):2313-20. PubMed ID: 19841089 [TBL] [Abstract][Full Text] [Related]
3. Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling. Yang YK; Yang C; Chan W; Wang Z; Deibel KE; Pomerantz JL J Biol Chem; 2016 Dec; 291(50):25921-25936. PubMed ID: 27777308 [TBL] [Abstract][Full Text] [Related]
4. Trimeric G protein-CARMA1 axis links smoothened, the hedgehog receptor transducer, to NF-κB activation in diffuse large B-cell lymphoma. Qu C; Liu Y; Kunkalla K; Singh RR; Blonska M; Lin X; Agarwal NK; Vega F Blood; 2013 Jun; 121(23):4718-28. PubMed ID: 23632891 [TBL] [Abstract][Full Text] [Related]
5. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association. McCully RR; Pomerantz JL Mol Cell Biol; 2008 Sep; 28(18):5668-86. PubMed ID: 18625728 [TBL] [Abstract][Full Text] [Related]
7. Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma. Nagel D; Bognar M; Eitelhuber AC; Kutzner K; Vincendeau M; Krappmann D Oncotarget; 2015 Dec; 6(39):42232-42. PubMed ID: 26540570 [TBL] [Abstract][Full Text] [Related]
8. A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival. Chan W; Schaffer TB; Pomerantz JL Mol Cell Biol; 2013 Jan; 33(2):429-43. PubMed ID: 23149938 [TBL] [Abstract][Full Text] [Related]
9. Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma. Yang Y; Kelly P; Shaffer AL; Schmitz R; Yoo HM; Liu X; Huang DW; Webster D; Young RM; Nakagawa M; Ceribelli M; Wright GW; Yang Y; Zhao H; Yu X; Xu W; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza L; Staudt LM Cancer Cell; 2016 Apr; 29(4):494-507. PubMed ID: 27070702 [TBL] [Abstract][Full Text] [Related]
10. Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Bidère N; Ngo VN; Lee J; Collins C; Zheng L; Wan F; Davis RE; Lenz G; Anderson DE; Arnoult D; Vazquez A; Sakai K; Zhang J; Meng Z; Veenstra TD; Staudt LM; Lenardo MJ Nature; 2009 Mar; 458(7234):92-6. PubMed ID: 19118383 [TBL] [Abstract][Full Text] [Related]
11. Intramolecular Interactions and Regulation of Cofactor Binding by the Four Repressive Elements in the Caspase Recruitment Domain-containing Protein 11 (CARD11) Inhibitory Domain. Jattani RP; Tritapoe JM; Pomerantz JL J Biol Chem; 2016 Apr; 291(16):8338-48. PubMed ID: 26884334 [TBL] [Abstract][Full Text] [Related]
12. Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity. Pérez de Diego R; Sánchez-Ramón S; López-Collazo E; Martínez-Barricarte R; Cubillos-Zapata C; Ferreira Cerdán A; Casanova JL; Puel A J Allergy Clin Immunol; 2015 Nov; 136(5):1139-49. PubMed ID: 26277595 [TBL] [Abstract][Full Text] [Related]